11 January 2024

Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) expert Ken Karipidis has been elected incoming International Commission on Non-Ionizing Radiation Protection (ICNIRP) Vice Chair.  

A/Prof Karipidis, ARPANSA's Health Impact Assessment Assistant Director, notes that ICNIRP is regarded as the leading health authority on non-ionising radiation protection.  

‘This is a fantastic opportunity to contribute to the international effort to further understand non-ionising radiation exposure and protection,’ A/Prof Karipidis said.  

‘Where countries don't have their own guidelines or regulations they rely on ICNIRP.  

‘In Australia, we also use ICNIRP’s guidelines to inform the development of our own exposure standards. 

‘I look forward to working with ICNIRP and bringing this experience to my role at ARPANSA undertaking research, developing safety standards, and providing public health advice related to non-ionising radiation exposure and protection.’  

Working with international health authorities, like ICNIRP, allows ARPANSA to ensure that international best practice is applied to the protection of people and the environment from the harmful effects of radiation in Australia.    

A/Prof Karipidis’ appointment will commence July 2024. He first joined ICNIRP in 2015 as a member of the scientific expert group. Prior to being elected Vice Chair, he served as chair of the non-ionising radiation for cosmetic purposes project group from 2018 to 2019 and joined the main commission in May 2020. He is currently chairing the low frequency guidelines project group which is related to the safety of power lines and other electrical equipment and infrastructure. 

For further information: 

• ICNIRP’s Announcement of Commission Membership 2024-2028  

11 December 2023

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) contributed to the newly released Australian Institute of Sport (AIS) sun safety position statement, which aims to protect people involved in sports from cancer-causing UV radiation. 

AIS Chief Medical Officer Dr David Hughes says participating in outdoor sports exposes not only athletes, but also coaches, officials, volunteers and spectators to prolonged periods of time outside. This means high levels of exposure to UV radiation from the sun.

‘Australia has the highest rates of skin cancer in the world and athletes participating in outdoor sports may be at greater risk for skin cancer because of high cumulative sun exposure, inadequate use of sun protection, and low skin cancer health literacy,’ said Dr Hughes AM. 

ARPANSA’s Ultraviolet Radiation Science Officer, Dr Kerryn King, who contributed to the statement, says this position statement is a step forward in assisting sporting organisations to recognise the inherent risk of UV radiation exposure in sports and to take action to cultivate positive sun protection behaviours for all participants.

‘With solar UV radiation responsible for at least 95% of skin cancers in Australia, we know that the more an individual is exposed to UV radiation, the greater their risk of developing skin cancer,’ said Dr King. 

‘It really boils down to ensuring the implementation of sun safe practices, such as the promotion of Slip, Slop, Slap, Seek and Slide behaviours.’ 

The position statement also provides strategies for reducing UV exposures. This includes recommendations for training and educating staff, communicating sun safety, and implementing sun protection policies. It also recommends sun protective clothing and uniform policies that ensure appropriate skin coverage and eye protection. 

The new position statement is available to read on the AIS website. 

It was developed by the AIS alongside leading sporting and health authorities including ARPANSA, Paddle Australia, Cancer Council and the Melanoma Institute of Australia. 

1 December 2023

The Australian Radiation Protection and Nuclear Safety Agency’s (ARPANSA) collaborative approach to measuring and communicating radiation risk was highlighted as a case study in the 2022-2023 Australian Public Service Commission State of the Service Report, which was tabled in parliament on 29 November 2023.

ARPANSA’s Radiation Research and Advice Director, Sarah Loughran, says the agency’s Electromagnetic Energy Program serves the Australian community by conducting research, developing safety limits, and providing public health advice.

‘We work closely with other government organisations such as the Australian Communications and Media Authority (ACMA), who enforce the safety limit we developed, to inform the public about their exposure to radio waves from wireless technology,’ said A/Prof Loughran.  

‘Both ARPANSA and ACMA publish complementary information on their communication channels which show the community that their exposure to radio waves is low, and well below the safety limit.

‘At ARPANSA, we’ve seen the positive impact that our research and radio wave measurements have had. Our Talk to a Scientist program is receiving the same number of enquiries each year, however, we’re answering fewer calls about 5G and more calls about ionising and UV radiation.

‘This better reflects Australians’ true radiation risk,’ she said.

The State of the Service Report found that in 2022–23, levels of trust in Australian public services remained stable with 61% of respondents indicating that they trust these services. There is even more trust, namely 73%, in the services they have specifically used.

Australian Public Service agencies, including ARPANSA, work extensively with government and non-government organisations, industry and research institutions to identify and respond to community needs such as protecting people and the environment from the harmful effects of radiation.  

Further information:

• The 2022-2023 State of the Service Report
• Australian Communications and Media Authority’s EME checker
• ARPANSA’s survey of radio wave exposure 2022

28 November 2023

A delegation from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) visited the United Kingdom’s Office for Nuclear Regulation (ONR) in November 2023 following an information sharing agreement that was signed between the two agencies in September. 

ARPANSA’s Chief Executive Officer, Dr Gillian Hirth, said that the three-day visit was part of a commitment towards increased regulatory cooperation and collaboration. 

‘This visit allowed us to further build on our relationship with ONR to share information on our regulatory experiences and discuss strategies for workforce and nuclear knowledge development,’ Dr Hirth said.  

‘These discussions provided a demonstration of the UK’s nuclear regulation in action, providing critical knowledge to support the highest standards of safety in Australia’s changing nuclear landscape.’ 

ONR’s Director of Regulation, Donald Urquhart, said the visit aimed to bolster ARPANSA’s understanding of how ONR regulates the UK nuclear sector, engages with industry licensees, and where necessary, implements enforcement action to influence proportionate improvements.   

‘We were delighted to welcome ARPANSA to Bootle for this valuable opportunity to share learning, ultimately helping to enhance nuclear and radiation safety between our respective nations,’ he said.  

‘Following the signing of our information sharing agreement with ARPANSA in September we look forward to continuing our work with the international nuclear community.’ 

At the International Atomic Energy Agency (IAEA) General Conference in Vienna, ARPANSA and ONR signed an Information Exchange Agreement to share information, experience and good practice.  

Working with international counterparts to enhance nuclear safety is a key aspect of ARPANSA’s role to protect people and the environment from the harmful effects of radiation.

9 November 2023

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) will provide $150,000 in funding to support the World Health Organization’s (WHO) research into the potential health effects of radio wave exposure on the general and working population.

ARPANSA’s Chief Radiation Health Scientist, Dr Rick Tinker, says that the findings from this research will be published as a WHO monograph.

‘The funding will specifically support the work of a WHO task group into the health effects of radio waves,’ Dr Tinker said.

‘As a member nation, the Australian Government supports the WHO’s independent assessment of all the scientific evidence on this topic.’

ARPANSA is one of WHO’s collaborating centres for radiation protection. This relationship allows WHO to access resources at ARPANSA, such as technical advice on radiation protection.

WHO’s Radiation and Health Unit Head, Dr Emilie van Deventer, says that the funding they have received from Australia and other member nations will assist in providing updated health assessment on radio wave safety to all 194 member states.

‘The task group’s work is important as we evaluate the latest scientific evidence on potential health effects from radio waves,’ Dr van Deventer said.

‘This work will help support the development of best-practice guidelines and national legislation to ensure that people remain protected from radio wave exposure.’

27 October 2023

Australia has made significant progress in building a resilient and adaptable regulatory infrastructure for radiation safety, according to a team of International Atomic Energy Agency (IAEA) experts.

ARPANSA hosted the Integrated Regulatory Review Service (IRRS) team during the 9-day follow-up mission, which was tasked with reviewing Australia's progress in implementing recommendations and suggestions made during an initial IRRS mission in 2018. 

'The IRRS is an internationally recognised process that strengthens regulatory effectiveness. Countries that invite missions - including Australia - demonstrate openness and transparency,' said Hildegarde Vandenhove, head of the IAEA Division of Radiation, Transport and Waste Safety.

The mission involved a series of interviews with ARPANSA, government representatives and the State and Territory regulatory bodies, and a review of relevant reference documentation prepared in advance of the visit.

ARPANSA CEO Dr Gillian Hirth is pleased with the outcomes and recommendations identified by the IRRS team.

'The follow up mission has provided an important evaluation of Australia's progress since 2018, during what has been a challenging period globally,' said Dr Hirth.

'With the changing nuclear landscape in Australia, it has been valuable to demonstrate our strong commitment to radiation and nuclear safety and also the progress made as we work towards consistent radiation protection for all Australians. We are extremely thankful to all mission participants for lending their expertise to evaluate and advise on how Australia can enhance its regulatory frameworks in line with international best practice.'

The IRRS team also identified areas for potential enhancements, such as the completion of a national strategy on radiation safety. Noting ongoing activities to address consistency in the State and Territories radiation safety programs, the team said further efforts were warranted in this area, which the establishment of a national strategy would support.

The IRRS team was comprised of seven senior regulatory experts from Canada, Finland, France, Ireland, United Kingdom, United States of America, and three IAEA staff members.

The final mission report will be provided to the Government in early 2024.

1 November 2023

The 2022-23 annual report of the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) was tabled in Parliament on 18 October and is now available in the Federal Government's Transparency Portal.

The report covers the activities of the Chief Executive Officer (CEO), ARPANSA and its supporting committees, as well as ARPANSA’s performance against key activities and financial objectives.

Highlights include: 

• insights into ARPANSA's provision of nuclear safety assistance to Ukraine 
• the new national primary standard for the dosimetry of ionising radiation
• our involvement in the hunt for a missing radioactive source in Western Australia
• progression of the Australian Government’s Electromagnetic Energy (EME) Program.

Looking back on the past year, ARPANSA CEO Gillian Hirth said she was proud of how the agency has responded to the demands created by Australia's rapidly evolving nuclear regulation landscape – such as the need to retain and attract suitably qualified staff.

‘The Federal Government's announcement of the optimal pathway for the acquisition of conventionally armed nuclear-powered submarines under the Australia, United Kingdom and United States (AUKUS) partnership has created both challenges and new opportunities for the agency,' said Dr Hirth.

'This year's report outlines how we have ably met these challenges, while also ensuring the agency's business as usual activities successfully achieved our purpose of protecting the Australian people and the environment from the harmful effects of radiation.' 

The report also highlights some of ARPANSA’s close and productive partnerships with academic institutions, research bodies and professional associations, and how these connections have helped the agency share ideas and expertise with students, as well as expand our own research capabilities. 

'Our ongoing partnerships with tertiary institutions have been mutually beneficial, and also help to support our aim of establishing ARPANSA as an employer of choice for STEM graduates and scientific experts', said Dr Hirth. 

Read the full ARPANSA Annual Report 2022-23 on the Commonwealth Government Transparency Portal .

4 October 2023

ARPANSA is seeking nominations for 3 members of the Radiation Health Committee (RHC). The Committee advises the CEO on a range of radiation protection matters. It helps draft national policies, codes and standards on radiation protection, to promote and enable consistent regulation in Australia.

ARPANSA is seeking to appoint:

• One member to represent the interests of the general public
• Two members with relevant knowledge and expertise in radiation safety.

Applicants should possess in-depth knowledge, qualifications or industry experience in radiation protection, including:

• radiation protection or radiation health
• radiation risk management principles and frameworks, and management systems
• plant, equipment and process safety related to radiation or radioactive materials
• specialist areas such as non-ionising radiation, medical radiation, waste or transport.

The CEO of ARPANSA will also be appointing a Chairperson from the RHC’s membership to actively lead its functions.

All appointments are part-time, and nominations are open for terms of up to 3 years, commencing 1 January 2024. 

To nominate, please email the RHC Secretariat your CV detailing relevant experience for the role, as well as the position you are applying for by Friday, 20 October 2023.

If you are interested in joining, you are encouraged to learn more about the functions and current membership of the Radiation Health Committee.

Find out more about how you can nominate today. And for further information about the roles and expectations for advisory bodies, please read our guidelines.

We look forward to announcing the 2024-2026 Committee in due course.

2 October 2023

ARPANSA regulates Commonwealth entities that use or produce radiation. 

The Australian Nuclear Science and Technology Organisation (ANSTO) is one of ARPANSA’s major licence holders and has submitted an application to decommission a nuclear installation, known as the High Flux Australian Reactor (HIFAR), at Lucas Heights Science and Technology Centre in Lucas Heights, New South Wales.

ARPANSA CEO, Dr Gillian Hirth, intends to make a decision in relation to the licence application.

The licence application is currently open for public feedback and we are particularly interested in hearing from members of the local community in the Sutherland Shire in Greater Sydney.

Prior to making any decision, Dr Hirth will consider all input gathered as part of the consultation process.

ARPANSA will be hosting an online forum to provide an outline of the application and the review and decision-making process. This will provide information to interested people to support their engagement in the consultation process.

The online forum aims to provide information to the community about the application and the consultation process. Participants are then welcomed to make a formal submission to the consultation process.

The online forum will include presentations covering: 

• An overview of the proposed decommissioning application
• The ARPANSA regulatory assessment process for this licence application
• Information on how to make submissions to the formal consultation. 

 There will also be an opportunity for questions from attendees. 

The online forum will take place on Monday 9 October from 6pm AEDT. 

To register for this event, please contact public.submissions@arpansa.gov.au

Registrations close 12pm AEDT, Monday 9 October 2023.

For further information or to make a submission to the consultation visit: HIFAR Decommissioning Phase A licence application. Submissions close Monday 8 December 2023.

21 September 2023

ARPANSA has launched new eye monitor technology to help medical workers track photon and beta radiation doses to the lens of their eyes.

Workers can use the eye dosimeter to track their eye radiation exposure levels over time and ensure that they are within the safe limits prescribed by regulatory standards.

The new monitors have been designed to support the health and safety of workers in occupations such as interventional radiology, interventional cardiology, medical imaging, and other industries that use ionising radiation.

Personal Radiation Monitoring Service (PRMS) Assistant Director Stephen Marks believes the new equipment meets a critical gap in the radiation protection market.

‘Our eyes are particularly sensitive to radiation and can be vulnerable to damage if exposed to excessive doses,' said Mr Marks.

‘That's why we're passionate about empowering workers in the medical field to safeguard their eye health.

‘The data gained from the monitors can also be used by employers and radiation safety officers to assess the effectiveness of radiation shielding measures and implement necessary adjustments to protect workers' eyes.’

The eye monitors easily attach to a headband or radiation safety glasses. It is recommended that eye monitors are used in addition to other monitors that measure radiation exposure to the torso, such as the Optically Stimulated Luminescence (OSL) whole body monitor.

‘Radiation is a critical tool in many medical and industrial applications, so it is important that we keep workers safe and monitor exposure to ensure they are protected from any harmful effects,’ said Mr Marks.

Find out more: PRMS eye monitors.